Antifungal Resistance Infographics
The following infographics provide practical guidance on resistant dermatophyte and Aspergillus spp. infections.
Nonaccredited Education
We have developed a range of educational materials in conjunction with our collaboration with the Centers for Disease Control. Please check out the resources below:
Video Interview: Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae
This interview features a discussion with 2 of the authors of the recent MMWR publication of the first cases of resistant ringworm caused by Trichophyton indotineae reported in the United States. The interview features Jeremy A.W. Gold, MD, of the Mycotic Diseases Branch of the CDC, and Avrom S. Caplan, MD, of the Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, in New York.
Call for Cases of Challenging Invasive Fungal Infections
Do you have an interesting case of an IFI in a patient with COVID-19? Or a challenging case of candidiasis or endemic mycoses? Please consider sending your case to us. We are compiling a range of cases for discussion that illustrate diagnostic and management challenges for these difficult infections. Select cases will be workshopped by our expert faculty.
Care Step Pathway for a Suspected Pulmonary COVID-19-Associated IFI
The primary goal of this initiative is educating and preparing clinical providers and public health workers to address the needs of the population of COVID-19 patients most seriously compromised by the disease, specifically those with respiratory failure requiring mechanical ventilation who are at risk for or who subsequently develop COVID-19-associated pulmonary aspergillosis (CAPA) or other COVID-19-associated invasive fungal infections (CA-IFIs).
COVID-19-associated Invasive Fungal Infection – OFID publication
Published as an editor’s choice article in Open Forum Infectious Diseases on November 16, 2021, COVID-19-associated Invasive Fungal Infection was written by faculty members of the COVID-19-associated Fungal Infections Educational Initiative as well as a medical epidemiologist from the Center for Disease Control and Prevention (Brendan Jackson, MD, MPH). Under the leadership of John W. Baddley, MD, and George R. Thompson, III, MD, the authors addressed a range of salient topics.
Mucormycosis Infographic
COVID-19-associated mucormycosis has ravaged India. With an eye toward early recognition and treatment, we have created this infographic to inform both healthcare providers and patients about mucormycosis.
The MRC CMM would like to invite you to their quarterly Myco-Clinics, where clinical experts in Medical Mycology will be presenting cases highlighting the challenges and new observations in the clinical recognition, diagnosis and management of fungal diseases.
Ahmed Fahal: Pulmonary metastatic eumycetoma an unusual complication: Case series and literature review.
Mervyn Mer: Candida and Conduits
17 June 2022, 16:00 BST, 8:00 PDT, 10:00 CDT, 11:00 EDT
CDC Fellowship related to antifungal resistance with the Mycotic Diseases Branch (MDB)
The Mycotic Diseases Branch (MDB) has three exciting training opportunities for qualified candidates. This is being offer through the Oak Ridge Associated Universities – ORAU.
Opportunities are as follows:
- Fungal Identification and Susceptibility Testing Training
https://www.zintellect.com/Opportunity/Details/CDC-DFWED-2022-0131
- Drug-resistant Fungi Epidemiologic Data Analyses
https://www.zintellect.com/Opportunity/Details/CDC-DFWED-2022-0132
- Understanding Emergence of Azole-resistant Aspergillus Fumigatus in the U.S.
https://www.zintellect.com/Opportunity/Details/CDC-DFWED-2022-0133
Opportunities are open to the public for recent STEM graduates. Application period is open now through 5/23/22 @ 3:00pm.
Direct all questions to MDB Workforce (CDC) MDBWorkforce@cdc.gov.